Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 238,360 | reported | 20 Nov 2025 | tx 2+128,428 |
| Aegerion Pharmaceuticals, Inc. | 40,000 | reported | 04 Aug 2015 | tx 3+74,000 |
| PharmaFrontiers Corp. | 5,858 | reported | 02 Mar 2020 | tx 5+176,000−3,142 |
| Flexion Therapeutics Inc | 0 | reported | 19 Nov 2021 | tx 4+239,750−239,750 |
| AKCEA THERAPEUTICS, INC. | 0 | reported | 12 Oct 2020 | tx 4+287,500−287,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 98,652 | 0.00 USD | deriv |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 29,776 | 0.00 USD | deriv |
| 19 Nov 2021 | OTHER | Flexion Therapeutics Inc | 34,250 | 8.50 USD | |
| 19 Nov 2021 | OTHER | Flexion Therapeutics Inc | 205,500 | — | deriv |
| 02 Aug 2021 | GRANT_AWARD | Flexion Therapeutics Inc | 34,250 | 0.00 USD | |
| 02 Aug 2021 | GRANT_AWARD | Flexion Therapeutics Inc | 205,500 | 0.00 USD | deriv |
| 12 Oct 2020 | TENDER | AKCEA THERAPEUTICS, INC. | 37,500 | 18.15 USD | |
| 12 Oct 2020 | OTHER | AKCEA THERAPEUTICS, INC. | 250,000 | 4.86 USD | deriv |
| 09 Jul 2020 | GRANT_AWARD | AKCEA THERAPEUTICS, INC. | 37,500 | 0.00 USD | |
| 09 Jul 2020 | GRANT_AWARD | AKCEA THERAPEUTICS, INC. | 250,000 | 0.00 USD | deriv |
| 02 Mar 2020 | TAX_WITHHOLDING | PharmaFrontiers Corp. | 3,142 | 3.28 USD | |
| 18 Sept 2019 | GRANT_AWARD | PharmaFrontiers Corp. | 40,000 | 0.00 USD | deriv |
| 01 Mar 2019 | GRANT_AWARD | PharmaFrontiers Corp. | 9,000 | 0.00 USD | |
| 01 Feb 2019 | GRANT_AWARD | PharmaFrontiers Corp. | 27,000 | 0.00 USD | deriv |
| 04 Oct 2017 | GRANT_AWARD | PharmaFrontiers Corp. | 100,000 | 0.00 USD | deriv |
| 04 Aug 2015 | GRANT_AWARD | Aegerion Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 01 Apr 2015 | GRANT_AWARD | Aegerion Pharmaceuticals, Inc. | 7,000 | 0.00 USD | deriv |
| 01 Apr 2015 | GRANT_AWARD | Aegerion Pharmaceuticals, Inc. | 27,000 | 0.00 USD | deriv |